Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors. (Q53077635)

11 May 2018

title

Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors. (English)

1 reference

11 May 2018

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

Myung-Won You

1

1 reference

11 May 2018

Jin Hee Kim

2

1 reference

11 May 2018

Jae Ho Byun

3

1 reference

11 May 2018

Hyoung Jung Kim

4

1 reference

11 May 2018

Seung Soo Lee

5

1 reference

11 May 2018

Myung-Hwan Kim

6

1 reference

11 May 2018

Moon-Gyu Lee

7

1 reference

11 May 2018

language of work or name

English

0 references

publication date

28 February 2014

1 reference

11 May 2018

published in

European Radiology

1 reference

11 May 2018

volume

24

1 reference

11 May 2018

issue

5

1 reference

11 May 2018

page(s)

1039-1048

1 reference

11 May 2018

Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease

cites work

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Atypical manifestations of IgG4-related sclerosing disease in the abdomen: imaging findings and pathologic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Extrapancreatic lesions in autoimmune pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Diagnostic Strategy for Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Is an Endoscopic Retrograde Pancreatography Essential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Standard steroid treatment for autoimmune pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Lymphoplasmacytic sclerosing cholangitis: assessment of clinical, CT, and pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Treatment and relapse of autoimmune pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Autoimmune pancreatitis, Part II: the relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00330-014-3127-8

Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis

1 reference

12 December 2020

Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012

1 reference

12 December 2020

High serum IgG4 concentrations in patients with sclerosing pancreatitis

1 reference

12 December 2020

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

1 reference

12 December 2020

Biliary tract involvement in autoimmune pancreatitis.

1 reference

12 December 2020

A case of advanced-stage sclerosing cholangitis with autoimmune pancreatitis not responsive to steroid therapy

1 reference

12 December 2020

Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis

1 reference

12 December 2020

Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI

1 reference

12 December 2020

10.1007/S00330-014-3127-8

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018